American Journal of Kidney Diseases

From WikiMD's WELLNESSPEDIA

American Journal of Kidney Diseases (AJKD) is a peer-reviewed medical journal focusing on the study of kidney diseases and related disorders. Established in 1981, it serves as a prominent source of scientific and clinical research articles, reviews, and updates in the field of nephrology. The journal is published by Elsevier on behalf of the National Kidney Foundation, emphasizing its commitment to the advancement of kidney health and care.

Overview[edit]

The American Journal of Kidney Diseases aims to inform and assist nephrologists, internists, and other healthcare professionals involved in the diagnosis, treatment, and management of kidney diseases. The journal publishes a wide range of content, including original research, critical reviews, editorials, and case reports, with a focus on novel findings and developments in nephrology.

Scope[edit]

The scope of AJKD covers various aspects of kidney diseases, including:

Publication Frequency[edit]

AJKD is published monthly, providing timely updates on the latest research and developments in the field of nephrology.

Indexing and Abstracting[edit]

The journal is indexed and abstracted in several major databases, including PubMed, MEDLINE, Scopus, and the Science Citation Index Expanded. This ensures its content is accessible to a wide audience of researchers and healthcare professionals.

Impact Factor[edit]

The American Journal of Kidney Diseases has a notable impact factor, reflecting its influence and importance in the field of nephrology and the broader medical community.

Editorial Board[edit]

The editorial board of AJKD consists of a diverse group of leading experts in nephrology from around the world. Their expertise ensures the high quality and relevance of the journal's content.

Access[edit]

Subscribers have full access to the journal's content, including current and archived issues. Institutions and individuals can subscribe directly through Elsevier or access the journal through various library and institutional subscriptions.

External Links[edit]

Stub icon

This article about an academic journal is a stub. You can help WikiMD by expanding the page.

See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=American_Journal_of_Kidney_Diseases&oldid=6529699"